Use of CMV unselected blood products does not increase the risk of CMV reactivation in patients undergoing hematopoetic stem cell transplant (HSCT).
Authors
Peters, JayneElliott, Jonathon
Bloor, Adrian
Dennis, Michael
Murray, John
Cavet, James
Somervaille, Tim C P
Sommerfeld, Sven A
Mutton, Ken
Mamat, Mohd K
Guiver, Malcolm
Kulkarni, Samar
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2015